Skip to main content
. 2017 Jun 17;9(6):623. doi: 10.3390/nu9060623

Table 2.

Baseline characteristics of participants after partition in quartiles according to IGF-1 concentrations.

IGF-1 Quartiles
Quartile 1 ≤89.5 ng/mL (n = 44) Quartile 2 89.6–111.0 ng/mL (n = 44) Quartile 3 111.1–143.0 ng/mL (n = 44) Quartile 4 ≥143.1 ng/mL (n = 43) p-Value for Trend
Age (years) 62 ± 8 62 ± 8 60 ± 11 57 ± 16 0.02
Females (%) 57 48 48 42 0.19
BMI (kg/m²) 32.0 ± 6.2 30.2 ± 4.0 30.3 ± 5.0 28.2 ± 4.4 0.001
Office Systolic BP (mmHg) 146 ± 15 142 ± 15 145 ± 15 139 ± 15 0.08
Office Diastolic BP (mmHg) 87 ± 10 87 ± 10 87 ± 11 88 ± 10 0.86
25(OH)D (ng/mL) 19.7 ± 6.0 22.1 ± 5.7 21.9 ± 5.1 20.9 ± 5.4 0.35
1,25(OH)2D (pg/mL) 47.9 ± 20.1 48.3 ± 17.3 52.5 ± 19.5 53.6 ± 18.9 0.10
PTH (pg/mL) * 55.2 (39.7–70.2) 44.0 (35.6–55.5) 53.1 (42.3–63.4) 48.1 (38.5–63.4) 0.94
Serum calcium (mmol/L) 2.36 ± 0.10 2.37 ± 0.11 2.36 ± 0.11 2.37 ± 0.10 0.87
Serum phosphate (mmol/L) 0.96 ± 0.14 0.96 ± 0.17 0.94 ± 0.18 0.96 ± 0.15 0.91
Diabetes mellitus (%) 52 34 25 30 0.02
Fasting glucose (mg/dL) * 121 (98–169) 100 (92–134) 96 (92–106) 94 (88–122) <0.001
HbA1c (mmol/mol) * 44 (38–57) 41 (38–56) 39 (36–45) 40 (36–47) 0.006
HOMA-IR * 2.49 (1.43–6.22) 2.11 (1.42–3.44) 1.72 (1.14–4.12) 1.53 (1.03–3.03) 0.23
eGFR (mL/min/1.73m²) 77.0 ± 20.1 80.0 ± 15.1 78.4 ± 18.7 80.1 ± 19.2 0.54
Triglycerides (mg/dL) * 116 (81–153) 128 (83–185) 126 (71–180) 116 (68–135) 0.46
HDL-cholesterol (mg/dL) 56 ± 13 58 ± 20 57 ± 19 57 ± 13 0.94
LDL-cholesterol (mg/dL) 104 ± 45 112 ± 42 120 ± 44 118 ± 30 0.08
CRP (mg/L) * 2.2 (1.0–4.9) 2.0 (1.2–3.8) 1.3 (0.9–2.6) 1.5 (0.6–3.8) 0.009

Data are shown as means with standard deviation, median, and interquartile range, or as percentages, whichever was appropriate. p-values for trends were calculated by ANOVA or chi-square test, whichever was appropriate. * Skewed variables for which logarithmic transformed values were used in ANOVA but untransformed values are shown in the table.